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ABSTRACT   
Background: Depression, Anxiety and Stress-Related Disorders, Common Mental Disorders 
(CMDs) are common among patients in primary health care, with many left untreated or even 
undiagnosed. CMDs are associated with high societal costs, and are the main cause of increasing 
Sick Leave among patients in primary health care. Effective treatments are not widely available in 
primary care. In addition, the associations between Clinical and Treatment-Related Factors, Patient 
Variables, Sick Leave and the Quality of Life are not well investigated. Research is needed in order 
to identify factors related to Health Outcomes, as well as to develop treatments that are well suited 
for primary care settings. 
Aims: The objective of the present thesis was to investigate the following: (a) The effects of two 
different group interventions for CMD in a primary care setting (Paper I), (b) the effects on active 
treatments on Sick Leave in a primary care setting (Paper II), (c) patient characteristics and their 
associations with the Quality of Life (QoL) (Paper III) and (d) how patient variables compared to 
treatments can predict QoL-one year after treatment (Paper IV).  
Methods: One large-scale randomized controlled trial (RCT) was conducted. In Paper I, a group 
intervention with a Transdiagnostic Manual based on Cognitive Behavioral Treatment(CBT) + 
Care as Usual(CAU) (n= 80) was compared to group with Multimodal Intervention(MMI) led by 
assistant nurses + CAU (n= 84) and CAU (n=81). Paper II compared treatment effects of group 
CBT + CAU (n=45) and MMI + CAU (n=58) compared to CAU (n=61) on Sick Leave. In Paper 
III, associations between patient variables and QoL were examined using a linear regression model. 
Paper IV examined associations between patient variables, treatment effects of group CBT + CAU, 
MMI + CAU or CAU and QoL one year after treatment, using a linear regression model. We used 
the Mental Component Summary (MCS) and the Physical Summary Score (PCS) of short form 36 
(SF-36) to measure QoL. 
Results: Study 1: the MMI + CAU group was significantly more improved than the CBT + CAU 
and CAU groups. The CBT + CAU group was significantly more improved than the CAU group. 
Study 2: The mean number of Sick Leave days decreased after randomization and the CBT and 
MMI interventions did not result in lower odds for sick listing compared with CAU. Study 3: 
Depressive Disorders and symptoms had the strongest effects on MCS. Study IV: background 
factors such as being employed, being born outside Sweden as well as having a Personality 
Disorder (PD) were strong predictors for QoL one year after treatment. The strongest positive 
predictor of MCS one year after treatment was the Group Treatment MMI. 
Conclusions: Transdiagnostic Group Treatment led by assistant nurses in a primary care setting 
can be effective for patients with CMD. Reduction in Psychological Symptoms and increased Well-
Being did not seem to have effect on Sick Leave. For primary care patients with mild to moderate 
Mental Illness, Mood Disorder and Depressive Symptoms were the strongest factors associated 
with negative influence on MCS. Effective Treatment and Being Employed had the strongest 
positive impact on QoL one year after treatment. PD had the strongest negative impact together 
with Being Born Outside Sweden. Increased priority for treatment of CMD in primary care is of 
great importance. 
Key words: Common Mental Disorders (CMDs), Primary Care, Transdiagnostic Group 
Treatments, Personality Disorder, Personality Traits, Predictors, Quality of Life, Sick Leave 
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3  INTRODUCTION  
By the time when the research plan underlying this thesis was created in 2002, the 
Gustavsberg Primary Care Center was serving 28,000 inhabitants and was one of the 
largest primary care centers in Sweden. As a manager of the care center since 1997, I had 
noticed that one of the greatest needs was to improve the care for patients with mental 
illness.  Primary care in 2002 was focused to a large extent on patients with diseases that 
cause early death, such as cardiovascular disease and diabetes. There was clearly much less 
focus on Common Mental Disorders, such as Depression and Anxiety. In the early 1990s, 
General Practitioners (GPs) were the sole caregivers in primary care for patients with 
Common Mental Disorders. Two events around this time, the introduction of SSRIs, 
(Selective Serotonin Reuptake Inhibitors) as anti depressive medication in primary care, as 
well as fundings by the Stockholm County Council to employ counselors, improved the 
care for some patients. 
In 2002, access to psychological treatment at our Primary Care Center was almost 
non-existent, although one counselor with basic training in psychotherapy had 
been employed  to give care to 28,000 inhabitants together with 15 general 
practitioners. Even though the prescriptions for anti-depressive medications 
increased every year, notings of Common Mental Disorders in the medical 
records were sparse possibly partly in order not to stigmatize the patients.  Thus, 
there was a great need to make Common Mental Disorders visible within primary 
care and to develop and evaluate treatment protocols with the goal of improving 
the care for patients with Common Mental Disorders. A pilot treatment project 
was started  in 2002 at the Gustavsberg Primary Care Center and was followed by 
the four studies comprising the present thesis. 
 
Gustavsberg , May, 2017 
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4 BACKGROUND 
4.1 COMMON MENTAL DISORDERS (CMDS) IN PRIMARY CARE 
CMDs stand for Common Mental Disorders. The term is used in international literature 
and usually includes the diagnoses Depression, Generalized Anxiety Disorder, Panic 
Disorder, Specific Phobias, Obsessive-Compulsive Disorder and Post-Traumatic Stress 
Disorder, according to the National Institute for Health and Care Excellence, NICE. 
CMDs in primary care usually include mild to moderate Depressive and Anxiety 
Disorders. Stress-Related Disorders, especially Acute Stress Disorder and Adjustment 
Disorder, are important conditions. In Sweden, the diagnosis “Exhaustion Syndrome”, 
described as a Prolonged Adjustment Disorder and recognized and accepted by the 
Swedish National Board of Health and Welfare (NBHW) since 2005, is handled in primary 
care, at least if the condition is not too severe. The detection and treatment of Alcohol 
Dependency is also a task for primary care and so is the case for Insomnia.  
Diagnostic and Statistical Manual of Mental Disorders, is a handbook and a guide in the 
diagnosis of Mental Disorders. It is published by the American Psychiatric Association 
(APA) and the first version was first published in 1952. The latest version of DSM was 
published in 2013 (DSM-5). In the present thesis, we used DSM IV. Somatic Syndrome 
Disorder has replaced Somatization Disorder and Undifferentiated Somatoform Disorder 
and Illness Anxiety Disorder has replaced Hypochondria in DSM-5. These conditions are 
also common in primary care.  
Obsessive-Compulsive Disorder (OCD) is described in DSM-5 as a separate diagnostic 
group and not, as previously, as a part of Anxiety Disorders. OCD is now described 
together with Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania (Hair-
Pulling Disorder) and Excoriation (Skin-Picking) Disorder. This group of disorders 
normally belongs to Specialist Psychiatric Care. The same is true for Psychotic Disorders 
and Bipolar Disorders. Table 1 shows Common Mental Disorders according to DSM-5 and 
their corresponding to ICD-10 codes (International Classification Diseases).  
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Table 1. Common Mental Disorders in primary care. DSM-5 and corresponding ICD-10 codes. 
 
4.1.1 Anxiety and Depression are Common Mental Disorders in Primary Care 
WHO predicts that Depression will be the diagnosis that contributes most to the burden of 
disease by the year 2030 [1]. Anxiety and Depressive Disorders are associated with a low 
Quality of Life (QoL) and are often left untreated in primary care [2-9]. Most of the Sick 
Leave due to Mental Illness in Sweden is caused by Anxiety, Depression and Stress-
Related Disorders [10-12]. There is a general agreement that there are Evidence-Based 
Treatments available for Anxiety and Depressive Disorders [13, 14] while the situation is 
not so clear for Stress-Related Disorders. There is evidence for the effectiveness of both 
Psychotherapeutic and Pharmacological treatments for Anxiety and Depression. However, 
in the Stockholm County Council (SLL) area, only 3% of the patients are offered other 
Treatments than Pharmacological Treatment [4].  
Common Mental Disorders in primary care   ICD-10          
    
Sleep-Wake Disorders  
Insomnia Disorder G47.00 
    
Substance-Related and Addictive Disorders   
Alcohol Use Disorder F10.2 
    
Depressive Disorders   
Major Depressive Disorder, single episode F32.0-F32.9 
   Mild F32.0  
   Moderate F32.1 
   Severe F32.2 
Major Depressive Disorder, recurring episode F33.0-F33.9 
Persistent Depressive Disorder (Dysthymia) F34.1 
    
Anxiety Disorders   
Agoraphobia F40.00 
Social Anxiety Disorder F40.10 
Specific Phobia F40.218-F40.298 
Panic Disorder F41.0 
Generalized Anxiety Disorder F41.1 
    
Obsessive-Compulsive Disorders   
Obsessive-Compulsive Disorder F42.0-F42.9 
    
Trauma- and Stressor-Related Disorders   
Acute Stress Disorder F43.0 
Adjustment Disorders, unspecified F43.20 
 F43.8A Exhaustion syndrome 
  
Somatic Symptom Disorder  F451  
Illness Anxiety Disorder F452  
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Depression and Anxiety Disorders are common worldwide [1, 5, 15] and the association 
between the two disorders is high. In a Swedish postal survey in 2013 [2] 17% of the 
responders were experiencing either Depression (10.8%) and/or Anxiety (14.7%). Around 
50% had both disorders. A low quality of life was associated with these disorders and the 
disorders were often untreated. In a national US survey in 2004 [6] the 12-month 
prevalence of Depression was 9.2% and the prevalence of Anxiety Disorders was 11.1%, 
which is similar to the results of the Swedish survey. The most common Anxiety Disorders 
were Specific Phobia (7.1%), Social Phobia (2.8%) and Generalized Anxiety Disorder 
(2.1%). Compared to population data, patients in primary care have, as expected, a high 
prevalence of Mental Disorders. In Belgium, a cross-sectional survey [15] discovered a 
Mental Disorder in over 40% of the primary care patients attending 86 different general 
practices. Mood Disorders were most frequent. In a cross-sectional study in Spain [5], a 
23% rate of Mental Disorders was found among the attendees of eight different Primary 
Care Centers. QoL was impaired in the patients with Mental Disorders, and the impairment 
was most pronounced in the patients with Mood Disorders In Sweden, it has usually been 
estimated that around every third patient visiting primary care suffers from CMDs [16, 17]. 
The impairment in the Health-Related Quality of Life (HRQoL) in primary care patients 
with Mental Disorders is generally considered to be larger than the impairment in patients 
with Common Somatic Disorders [18]. The patients who suffer from Anxiety and Mood 
Disorders often present with physical rather than psychological symptoms [19].   
Guidelines from the National Board of Health and Welfare (NBHW) for Treatments 
of Depression and Anxiety from 2016  
The latest guidelines from the Swedish NBHW for Depression and Anxiety 
(http://www.socialstyrelsen.se/publikationer2016/2016-12-6, December, 2016) highlight 
the importance of early interventions. They recommend that healthcare providers offer 
high availability to patients with symptoms of Depression and Anxiety in order to assess 
the degree of severity and offer treatment at an early stage. The guidelines state that 
patients with a Depression or Anxiety Syndrome who do not receive correct treatment at an 
early stage are at higher risk for decreased functional ability, long-term illness and disease 
relapse, as well as a higher risk of suicide.  
The recommendations suggest that these patients should be scheduled for regular follow-
ups since continuity is of great importance for detecting conditions that are more serious, 
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improving the prognosis, and increasing compliance. It is stated that offering high 
availability and continuity within the health-care system demands increased resources. 
According to the new guidelines, psychological interventions, preferably Cognitive 
Behavioral Therapy (CBT), are the main treatment for all conditions of mild to moderate 
Depression and Anxiety Disorders. Interpersonal Psychotherapy (IPT) is also 
recommended for mild and moderate cases of Depression as is, to a lower degree, Short-
Term Psychodynamic Therapy (PDT). 
Medical Products Agency and Recommendations from 2016 
New strategies and recommendations for the treatment of Depression and Anxiety 
Disorders were published in the fall 2016 by the Medical Products Agency (MPA), and are 
oriented toward various combinations of treatments and social/work-related interventions 
(https://lakemedelsverket.se/upload/halso-och- sjukvard/behandlingsrekommendationer/ 
Info_fran_LV_nr_6_2016_behandlingsrekommendation_webbpublicering.pdf).  
The agency states that both anti-depressive pharmaceuticals and specific psychotherapy 
(CBT or IPT) have a proven effect and that, in many cases, the combination of the two 
enhances the effect. Recommendations for moderate Depression include anti-depressives 
and/or psychological treatment with SSRI, such as escitalopram and sertraline, as the 
preferred drugs. It is highlighted that, in Depression, switches within the pharmacological 
group may be necessary and frequent follow-ups are recommended to re-estimate the 
symptoms. Great emphasis is placed on lifestyle changes. OCD is treated in the same way 
with CBT first, with or without SSRIs, in the same ranking as for the other Anxiety 
Syndromes.  For most cases of mild Depression, pharmaceuticals are not recommended. 
Physical activity is recommended for mild to moderate Depression with the optimal anti-
depressive dosing schedule being 30 minutes, 3 times per week, preferably led by an 
instructor. 
 
4.1.2  Stress-Related Disorders 
Stress-Related Mental Illness is the most common reason for Sick Leave in Sweden today, 
and one of the most common causes of decreased work capacity [10, 12, 20]. 
According to DSM-5, an acute stress reaction is a short-term, strong reaction to a traumatic 
event and is, by definition, diagnosed between three days and one month after experiencing 
or learning about the event. Symptoms begin after the event and fall into five categories: 
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negative mood, as well as intrusive, dissociative, avoidance, and arousal symptoms. Social, 
Interpersonal, or Occupational Functioning can be disrupted. Extreme levels of Anxiety 
can disturb sleep; interfere with the ability to tend to tasks and lower energy levels. 
Avoidance of stimuli related to the traumatic event can cause withdrawal and 
nonattendance at important events. 
Adjustment Disorder is a disproportionate reaction to one or more stressors in life, ranging 
from marital problems, and chronic illness or financial difficulties to living in a crime-
ridden community or surviving a natural disaster. Developmental changes such as moving 
away from home, becoming a parent or retirement may also trigger emotional or 
behavioral symptoms that can cause significant impairments of functioning at work, in 
school or socially. The symptoms can last up to six months after the stressor is no longer is 
present.  
The condition Exhaustion Syndrome, recognized and accepted by the Swedish National 
board of Health and Welfare since 2005, is classified according to the Swedish ICD-10 as 
diagnosis code F438A. Since 2016, this is the most common disorder causing Sick Leave 
in Sweden according to the Swedish Insurance Company. The patients are usually treated 
in primary care for mild to moderate degrees of this condition. In 2003, the National Board 
of Health and Welfare in 2003 (Table 2) described the diagnosis criteria.  
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Table 2. Criteria for Exhaustion Disorder. Source: The National Board of Health and Welfare.  
 Diagnostic criteria for Exhaustion Syndrome 
All criteria marked in capital letters must be satisfied in order fulfill the diagnosis. 
A Physical and mental symptoms of exhaustion for at least two weeks. The symptoms 
have developed as a result of one or more identifiable stressors which have lasted for at 
least six months. 
B A significant lack of mental energy dominates the image, which is reflected in decreased 
activity, reduced endurance or extended recovery time in connection with mental strain. 
C At least four of the following symptoms have occurred almost every day during the 
same two-week period: 
(1) Concentration Difficulties or Memory Disturbance 
(2) Significantly Impaired Ability to handle demands or to do things under time pressure 
(3) Emotional Lability or Irritability 
(4) Sleep Disorder 
(5) Significant Physical Weakness or Fatigue 
(6) Physical symptoms such as Aches, Chest Pain, Palpitations, Gastrointestinal 
Disorders, Dizziness, or Sensitivity to Sounds. 
D The symptoms cause a Clinically Significant Disorder or Impaired Function in Work, 
Social Life, or other important aspects. 
E Not due to direct physiological effects of any substance (such as Drug Addiction, 
Medication), or any Somatic Disease / injury (such as Hypothyroidism, Diabetes, 
Infectious Disease). 
F If the criteria of actual Depression, Dysthymia, or Generalized Anxiety Disorder are 
fulfilled at the same time, Exhaustion Syndrome is indicated only as supplementary 
specification for the current diagnosis. 
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From a medical point of view, the etiology is summarized as a long-term exposure to stress 
leading to physiological changes that have a long recovery period. According to a well-
known researcher on this subject, Marie Åsberg [21], the most common cause of this 
syndrome is regarded as an increase in work load over time without sufficient recovery 
time. This has been shown to often correlate with reorganizations in the work-place or a 
decrease in workforce. Women are affected much more often than men. The syndrome is 
characterized by fatigue which is not relieved by rest, cognitive problems (deficiencies in 
concentration, episodic memory and orientation), increased sensitivity of the senses (light, 
sound) and general increased sensitivity to stress. It is preceded by a longer period (by 
definition a minimum of 6 months) of stress. Usually a prodromal phase of physical 
symptoms has been present long before the syndrome is diagnosed. The acute phase that 
follows is often induced by a sudden increase in workload or troubles in the home 
situation. It is often dramatic and is referred to as “hitting the wall”. Marie Åsberg 
summarizes that so far, no scientific study has shown a rehabilitation model that is 
significantly better than any other, except models that include rehabilitation integrated with 
the work-place. Many patients report CBT as being helpful but does not shorten the sick 
leave time. Physical exercise is an essential part of rehabilitation as soon as patient is out 
of the acute phase. 
 
4.2 CMD IN PRIMARY CARE SINCE 1995 IN STOCKHOLM COUNTY 
Primary Care Centers in Stockholm County, approximately 180 in number, provide 
Primary Care to two million people. Since 1995, the Primary Care Centers in Stockholm 
County have been able to employ counselors/social workers with funding from the County 
Council. Some of the counselors had psychotherapeutic training and the general 
practitioners referred patients with different problems to them. No diagnostic procedure 
was required by the County Council, nor were assessments before and after treatment 
required. One, or perhaps two, counselors per 25,000 inhabitants and approximately one 
general practitioner per 2,000 to 3,000 inhabitants were the typical ratios. Since 2008, 
patients have been able to freely choose one of the 180 Primary Care Centers according to 
the political legislation. Around the year 2000, psychologists started to be employed. 
Primary Care Centers are fully paid by the County Council up to 1.9 visits to the GP per 
listed inhabitant, and there after there is a reduction per visit (33%). In 2008, the Primary 
Care Centers were fully paid, on average, for 0.1 visit to a counselor or psychologist per 
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year per listed inhabitant. Since then, the quotient has been slowly raised to 0.2 during 
2016 and up to 0.3 since 2017.  
Is an average of 0.3 visits annually per listed inhabitant enough to be able to provide 
evidence-based care according to the National Guidelines for Depression and Anxiety, 
published by the Swedish NBHW in 2016? In different studies [5, 6, 15-17], approximately 
25% of the patients in primary care in Sweden have been found to have a mental problem. 
In a Swedish study from 2014 [4] concerning all patients in Stockholm County, 7% had 
received a psychiatric diagnosis, while 17% had been prescribed psychotropic drugs and 
only 3% had visited a counselor or psychologist during 2011. 
According to a recently published report entitled “Time for Focus on Data for Common 
Mental Disorders in primary care, Stockholm County”, 73% of all patients in the 
Stockholm County Council Area with psychiatric diagnoses were given treatment in 
primary care and 26% of them also received treatment somewhere else during 2011-2015 
[22]. 
 
4.3 PSYCHOLOGICAL TREATMENTS: CBT, IPT, AND PDT 
Cognitive Behavioral Therapy - CBT 
CBT is a form of psychological treatment developed from behavioral, cognitive 
and social psychology [23, 24]. It is research-based and the emphasis lies more 
on understanding and changing the patient’s current life situation than 
investigating the past. The treatment components target the interplay between the 
individual and his/her environment and the primary therapeutic goal is to help the 
patient develop novel and more functional ways to function, feel, think, and 
handle problems. Behavioral change is a primary intervention in CBT, as 
opposed to being a secondary effect of the treatment, as in other 
psychotherapeutic models.  
Core CBT components include psychoeducation, exposure therapy, behavioral 
activation, behavioral experiments, cognitive techniques and homework 
assignments. Specific and measurable behavioral goals are set for each patient 
and one of the main aims of the therapy is to educate and empower the patient in 
order to increase self-efficacy. In the more recent development of CBT, 
components based on acceptance and mindfulness have been added to the 
therapeutic model.  
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CBT    Unified Protocol 
There is a large comorbidity between Common Mental Disorders [2, 5, 6, 25]. To 
address this situation, Dr. David Barlow, a well-known psychologist and researcher 
in Boston, developed a CBT-based manual for Transdiagnostic Psychological 
Treatment, also called Unified Protocol [25-27]. The manual has been developed 
for both Anxiety Disorders and Depression instead of different manuals for each 
diagnosis.  
 Patients with Anxiety Disorders experience feelings more frequently, more intensely, and 
more distressingly than people without these disorders. In Anxiety Disorders or Emotional 
Disorders, the experience of strong, uncomfortable emotions may create dysfunction in 
various areas of a person’s life. The strong emotions tend to be so distressing that the 
affected individuals might start to do things, or escape from certain situations, to avoid 
experiencing the intense feelings [25, 28]. According to the workbook “Unified Protocol for 
Transdiagnostic Treatment of Emotional Disorders” the following treatment goals are 
important for patients: 
 Learning to be an observer instead of a victim of one’s emotional experiences  
 Keeping ongoing records of one’s experiences 
 Learning to observe when and where uncomfortable emotions occur 
 Learning to recognize how thinking, feelings and actions can contribute to 
uncomfortable or distressing emotional experiences 
 Learning more helpful ways of coping with emotional experiences 
 Learning to record more objectively how many times certain feelings arise and the 
responses to those feelings (thoughts, actions and additional feelings) 
 Learning to identify specific triggers of Anxiety and Depression Episodes 
Interpersonal Psychotherapy - IPT 
Interpersonal psychotherapy was initially developed as a treatment for major Depression. 
The model primarily regards the negative emotions and depressive symptoms as effects of 
difficult social and interpersonal stressors [29]. The focus lies on the patients’ emotions 
and current life situation. Interpersonal difficulties are assessed in terms of disputes, 
bereavements, sensitivities and role transitions. Negative patterns are identified and broken 
in order to achieve an improvement in interpersonal functioning and a reduction in 
depressive symptoms.  
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Short-term Psychodynamic Therapy - PDT 
Psychodynamic Therapy focuses primarily on understanding the inner world of 
the patient, with an emphasis on the unconscious [30, 31]. Wishes, feelings, 
dreams and fantasies are explored. The impact of early developmental factors is 
important for understanding current psychopathology, even in short-term 
psychotherapy. The therapeutic relationship and dynamics between the therapist 
and the patient are also important aspects in PDT. Difficult symptoms are 
understood as conflicts between the conscious or unconscious needs or desires of 
an individual and restrictions in the environment.  
 
4.4 PERSONALITY TRAITS    
Personality has long been of interest to philosophers and scientists. Although psychologists 
are also interested in Personality Traits, there is less knowledge about how such traits 
affect public health [32]. 
Today, the dominant model in Personality Psychology is called The Big Five [33-36]. The 
Five Personality Traits are usually described as degrees of Extraversion, Neuroticism, 
Agreeableness, Conscientiousness, and Openness. 
Personality Traits are associated with both Mental and with Physical Health and, success in 
one’s professional life and are linked to the quality of Interpersonal Relationships [37]. 
Research has also shown that there is a link between Personality and certain Mental 
Disorders.  
Anxiety and Depression and are linked to both Neuroticism and low Extraversion [38, 39]. 
The links between Personality and Personality Disorders are strong and Personality 
Disorders have been suggested to be an extreme expression of Personality [40]. Research 
has shown that Personality has more influence on Subjective Well-Being than other 
variables such as Social Class, Marital Status, Age, and Employment [41]. 
There are associations between the Personality Trait High Degree of Extraversion and 
positive health outcomes [42]. Low Conscientiousness is related to smoking and lack of 
exercise [43]. There are strong associations between the Personality Dispositions and 
Anxiety Disorders, and Depressive Disorders, as well as Personality Disorders. Anxiety 
Disorders are associated with Neuroticism, and Depression is associated with Neuroticism 
and low Extraversion [38, 44].  
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4.5 PERSONALITY DISORDER 
Personality Disorder (PD) is generally defined as a pattern of thinking, feeling and 
behaving that deviates from the expectations of the socio-cultural environment. The main 
characteristic of PD is difficulties in interacting with other human beings [45]. PDs are 
common in all medical settings and every medical practitioner will meet them frequently. 
In the US, 50% of patients with any Mental Disorder have a PD, which makes it one of the 
most common psychiatric disorders [46]. People with PD had lower Quality of Life 
compared to a healthy population in a Finnish population-based sample [47]. Compared to 
patients with serious Somatic Illness Patients with a PD have in general low QoL [48, 49]. 
About a quarter of patients in primary care meet the criteria and prevalence in the general 
population is 5 - 10% [50-52]. In Swedish survey, the prevalence of PD was 11% in the 
whole population [53].  Many individuals remain undiagnosed and might be treated 
incorrectly or in a harmful way. In the US survey, there was a positive and significant 
association between the PDs, Anxiety Disorders and Depression. The PDs most strongly 
associated with Anxiety Disorders and Depression were Avoidant and Dependent PDs and 
the most prevalent PD was Obsessive-Compulsive Personality Disorder (7.9%). 
Common to all PDs is that the general diagnostic criteria must be met before further 
classification can be done. The pattern of behavior should be inflexible and prominent in 
various situations and circumstances. Traits should have been stable since adolescence and 
cause significant distress or problems in functioning. In addition, the personality pattern 
should not be better explained as an expression of another psychiatric illness or somatic 
disease, or be a direct physiological effect of a substance. The demarcation between 
clinical syndromes and personality syndromes is not always clear and comorbidity is very 
common.  
In both DSM-IV and in DSM-5, 10 different PDs are described. In this thesis, we used 
DSM-IV. In DSM-5, the PDs are divided into three clusters and are now parts of other 
psychiatric diagnoses. 
Cluster A: Paranoid PD, Schizoid PD, Schizotypal PD 
Individuals with these disorders are “odd” and reclusive and have a very limited social 
network. Their limited social skills cause them to have difficulties fitting in to working life. 
Cluster B: Antisocial PD, Borderline PD, Histrionic PD, Narcissistic PD 
Individuals with these disorders are outgoing, often dramatic, colorful, and conflict-prone. 
They can have problematic relationships with other people, as well as difficulties in the 
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workplace because of their impulsiveness, lack of empathy, or emotional instability. There 
are currently a number of different psychotherapeutic treatment programs specifically 
geared toward borderline disorder and have shown good results in controlled trials.  
Cluster C: Avoidant PD, Dependent PD, Obsessive-Compulsive PD  
Individuals with these syndromes are usually described as anxious and socially insecure, 
but, compared to patients with other Personality Disorders, their ability to function in the 
workplace is usually better. 
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Table 3. The DSM-5 alternative model for Personality Disorders. Section III in DSM-5.  
 
 
Personality  traits 
normal 
population 
 
 
“Big Five” 
Pathological  
variants 
of traits 
 
Facets  of traits 
 
 
6 Personality Disorders 
in   alternative model: 
Antisocial, avoidant, 
borderline, narcissistic, 
obsessive-compulsive and 
schizotypal PDs   (6 instead of 
10 ) 
Plus  PD- TS (trait 
specified) 
Neuroticism Negative affectivity Emotional lability Borderline 
 Vs.  Emotional  
Stability 
Anxiousness Avoidant, Borderline 
 
 
Separation insecurity Borderline 
 
 
Submissiveness  No specific PD associated 
 
 
Hostility Antisocial, Borderline 
 
 
Perseveration Obsessive-Compulsive 
 
 
    
Extraversion Detachment Withdrawal Avoidant, Schizotypal 
 Vs. Extraversion Intimacy avoidance Avoidant, Obsessive-
compulsive 
 
 
Anhedonia Avoidant 
 
 
Depressivity Borderline 
 
 
Restricted affectivity Obsessive-Compulsive, 
Schizotypal 
 
 
Suspiciousness Schizotypal 
 
 
    
Agreeableness Antagonism Manipulativeness Antisocial 
 Vs. Agreeableness Deceitfulness Antisocial 
 
 
Grandiosity Narcissistic 
 
 
Attention seeking Narcissistic 
 
 
Callousness Antisocial 
 
 
    
Conscientiousness Disinhibition Irresponsibility Antisocial 
 Vs Conscientiousness Impulsivity Antisocial, Borderline 
 
 
Distractibility  No specific PD associated 
 
 
Risk taking Antisocial, Borderline 
 
 
(Lack of) rigid 
perfectionism 
Opposite pole: Obsessive-
Compulsive 
Openness Psychoticism Unusual beliefs and 
experiences 
Schizotypal 
 Vs Lucidity Eccentricity Schizotypal 
   Cognitive and 
perceptual 
dysregulation 
Schizotypal 
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DSM-5 and ICD point out the potential for change in Personality Status over time rather 
than it being a lifelong label. Mortality is elevated in PD and life expectancy is shortened. 
General health is worse, as are problems with relationships and with health care personnel 
[54]. 
There has been much criticism of the current categorical diagnostic model and efforts have 
been made to develop a dimensional system [54]. An alternative model for Personality 
Disorders (Table 3) has been presented in DSM 5 [55]. This model introduces the concept 
of Dimensional Personality Traits as one of the core criteria, apart from impairment in 
Personality Functioning, as well as a novel diagnosis, Personality Disorder – trait-specified 
(PD-TS). PD-TS is an alternate diagnosis to Personality Disorder not otherwise specified 
(PD-NOS) and addresses the clinical issues that patients with one Personality Disorder 
frequently satisfy the criteria for other Personality Disorders, as well as the lack of 
specificity of the PD-NOS diagnosis. The proposed model retains six distinct Personality 
Disorder Diagnoses from the current diagnostic model: Antisocial Personality Disorder, 
Avoidant Personality Disorder, Borderline Personality Disorder, Narcissistic Personality 
Disorder, Obsessive-Compulsive Personality Disorder and Schizotypal Personality 
Disorder. The remaining four PDs in the current diagnostic model are included in the PD-
TS diagnosis (APA, 2013).  
 
4.6 SICK LEAVE 
Figure 1 shows that Sick Leave in Sweden has fluctuated considerably over time [11, 12]. 
There was a peak around the year 2000 and, from around 2004, Common Mental Disorders 
predominate diagnoses behind Sick Leave. Until then low back problems had been the 
predominant cause of sickness absence [10-12].  
Common psychiatric disorders, such as Anxiety, Depression and Stress, are now the most 
common reason for Long-Term Sick Leave in European Countries [56, 57]. Sick Leave 
contributes to a large burden on the economies in Developed Countries.  Only 20% of 
those who are on Sick Leave in Great Britain for longer than 6 months return to work [56, 
57].  
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Figure 1. Number of ongoing spells of Sick Leave > 28 days in December 1974 - 2016.   
Source: Swedish Social Insurance Agency 
 
 In Sweden there has been a large increase in Sick Leaves due to psychiatric diagnoses since 
2009 (Figure 2), mainly Stress Disorders [12]. The risk factors in the workplace that has 
been discussed over time is mentally exhausting work, high demand, low control, and an 
imbalance between effort and reward [10].  
 
 
Figure 2. Number of new Sick Leave spells of > 14 days by Mental Disorder Diagnosis (ICD-10) 
Source: Korta analyser (Brief Analyses) 2016:2  Psykisk ohälsa (Mental Illness). Swedish Social Insurance Agency. 
 
Other researchers [58] hypothesize that individual characteristics and cultural contexts are 
important factors with impact on Sick Leave. They point out that there is time trends with 
different disorders dominating at different times and this is hard to explain by occupational 
causes. For instance, back problems caused a large Sick Leave peak in the 1970s in Britain 
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and in the 1980s in Australia in the same way there was a peak in Sick Leave because of 
arm pain among office workers. [58, 59]. 
Individual factors are also important in the decision to take time off from work [59]. It has 
been suggested that when campaigns are started in order to reduce Stigma there is a risk 
that some individuals can medicalize transient minor symptoms. The little evidence 
available reveals an open field with a complex interaction between psychological, social, 
medical, and cultural factors [59]. 
In 2008, the Swedish government introduced the “Rehabilitation Guarantee” in order to 
support the counties in offering Cognitive Behavioral Therapy (CBT) for people with mild 
and moderate mental illness in primary care.  
The evaluation of the Rehabilitation Guarantee, [60] concluded that CBT effects are 
beneficial for patients who are not on Sick Leave at the time when treatment is initiated; 
CBT reduces Absenteeism and the number of Drug Prescriptions during the year after the 
start of Treatment, while the number of health care visits increased somewhat. For CBT 
patients who are on Sick Leave when the treatment is started, there is no effect on Sick 
Leave, but on the other hand, a decrease in the prescribing of medicines and an increased 
number of health care visits. In general, there is little evidence that Treatments that are 
effective for Symptoms also have an effect on Sick Leave for patients already on Sick 
Leave.   
 
4.7 QUALITY OF LIFE 
Quality of Life (QoL) has been described as including subjective Well-Being, Life 
Satisfaction, Perceptions of Social Relationships, Physical Health, and the Level of 
Functioning in Daily Activities and Work [24]. It has also been suggested that one should 
distinguish between QoL and Health Status [61], and that the two seem to be different 
constructs from the viewpoints of the patients. Patients attach more importance to Mental 
Health than to Physical Functioning when ranking the Quality of Life, and vice versa 
regarding Health Status [61]. The Health-Related Quality of Life (HRQoL) measure is 
used as a complement to Symptom Assessment in Medical Research because it reflects 
broader aspects of the burden associated with Disease, such as Global Functioning in 
various areas of everyday living [5]. 
HRQoL consists of at least three domains, Mental Health, Physical Functioning and Social 
Functioning.  
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Primary care patients with Mental Disorders have a substantially impaired QoL [18, 62, 
63]. The degree of impairment of the QoL varies with type of Mental Disorder, and is 
generally most pronounced for Mood Disorders [18, 64]. Different subtypes of Anxiety 
result in different degrees of impairment, with a more negative effect for Generalized 
Anxiety Disorder and Social Anxiety than for specific phobias [65]. Other variables 
besides psychiatric diagnoses and associated symptoms have different degrees of 
impact on the QoL. For example, older age is associated with more chronic disease 
and lower scores on the physical component of QoL [19] whereas social support and 
good economic conditions are associated with higher scores on all subscales on 
one widely used QoL instrument. QoL can be assessed using the SF-36 [66-68], a multi-
dimensional instrument that measures eight aspects of health: Physical Functioning (PF), 
Role limitations due to Physical health problems (RP), Bodily Pain (BP), General Health 
(GH) perceptions, Vitality energy/fatigue (VT), Social Functioning (SF), Role limitations 
due to Emotional problems (RE) and Mental Health (MH). SF-36 scores can be 
standardized using a mean of 50 points with a standard deviation of 10 points. Items 
reflecting physical aspects of the QoL (i.e., the first four items) are often summarized in a 
Physical Component Summary (PCS). Correspondingly, the last four items covering 
mental aspects make up the Mental Component Summary (MCS).  
 
 
 
 
 
 
 
 
 
 
 
 26 
5 AIMS OF THE PRESENT THESIS 
The general aims of the present thesis were to investigate the effects of two group 
interventions for patients with Common Mental Disorders in primary care and to describe 
this group of patients with an emphasis on their Quality of Life. Specific aims were as 
follows: 
 
5.1 PAPERS I AND II 
 
The aim in the first two studies was to investigate, in a Randomized Controlled Trial 
(RCT), the effectiveness of two Transdiagnostic Group Treatments, CBT and MMI as add-
ons to Care as Usual (CAU), compared to CAU for patients with Anxiety, Depressive and 
Stress-Related Disorders treated in a primary health care context.  In Paper I, the primary 
outcome was QoL Mental Component Summary (MCS) Score of Short Form-36 (SF-36) 
[66-69], secondary outcomes were reduction of Anxiety Depressive and Obsessive-
Compulsive Symptoms assessed with the Self-Rating Scale for Affective Syndromes 
(CPRS-S-A) [70], reduction of stress symptoms, the Perceived Stress Scale [71], while, in 
Paper II, the outcome was sick leave days. 
 
5.2 PAPER III  
 
The aim of Paper III was to describe primary care patients assessed to be in need of 
treatment for some Mental Disorder. The assessment focuses on their Diagnoses and 
Symptoms, Background Factors, Lifestyle, and Personality. A further aim was to elucidate 
how these variables are associated with the QoL. 
 
 
5.3 PAPER IV 
 
The aim of Paper IV was to describe the impact of different patient characteristics 
compared with the impact of psychological treatments on the QoL over time for patients 
with Mental Disorders in primary care. 
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6 ETHICS 
 
We obtained Ethical Approval 2005-06-16 for the randomized clinical trial (Paper I and II) 
from the Regional Ethics Committee in Stockholm, Dnr 2005/447-31. The approval was 
amended in 2006-06-21 regarding an additional follow-up assessment 6 months post 
treatment (Paper I) and in 2009-05-19 regarding an enquiry for permission to use sick 
leave data (Paper II). 
 
A new approval was obtained in 2015-02-12, from the Regional Ethics Committee in 
Stockholm, Dnr 2015/58-32, regarding comparisons of patient personality characteristics, 
background factors, and QoL (Papers III and IV). 
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7 STATISTICS 
 
7.1 PAPER I 
The data were analyzed using intention-to-treat. The primary end points were analyzed 
using a linear mixed model in which the responses at post assessment and the 1-year 
follow-up were included as dependent variables, and group, time and baseline values of the 
response variable were added as fixed factors in the model. The intercept of each subject 
was added as a random factor. Based on the linear mixed model, inferences could be made 
concerning the difference between groups and over time. Effect sizes were calculated using 
Cohen’s d. In addition to the primary analyses, several sensitivity analyses were performed 
to assess the robustness of the results.  
 
7.2 PAPER II 
A mixed model to analyze the effect of treatment and time was not considered useful since 
the residuals were not normally distributed, the number of days of sick leave per month 
usually being 0 or 30 days. Our primary outcome measure was therefore defined as odds 
(odds ratios, ORs) for being sick-listed or not in a comparison between groups at different 
points in time, adjusted for whether one was sick-listed before the start of the trial.  
 
7.3 PAPER III 
To evaluate the influence of the different variables, such as Life-style, Education, 
Personality or Diagnoses on the MCS and PCS Scales of the SF-36, a linear 
ANOVA/regression was performed. All continuous variables were dichotomized using a 
median-split. The model selection was based on the Aikaike Information Criterion.  
The OC Scale in CPRS-S-A is not included in the regression analyses in Papers III and IV 
since the questions are shared with the Anxiety and Depression Scales, except for two 
questions with a focus on OC. 
 
7.4 PAPER IV 
The variables measured before treatments were used to predict: (1) the two Summary 
Component Scales of the SF-36 at baseline. The same variables were also used together 
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with the variable “treatment”, CBT, MMI, or CAU, to predict: (2) the outcome of the two 
Summary Scales of the SF-36 one year after treatment. and the outcome of the two 
Summary Scales of the SF-36 one year after treatment. Linear backwards stepwise 
ANOVA/regressions were performed in which the model selection was based on the 
Aikaike information criterion. All continuous predictor variables were dichotomized using 
a median-split.  
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8 MATERIAL AND METHODS 
 
Trial Design 
The trial was an RCT with two group interventions (CBT and MMI) with CAU as control. 
The randomization was computer generated by a statistician who was not otherwise 
involved in the study. 
 
Participants and recruitment 
The patients were recruited for a randomized controlled trial [72], comparing two different 
group interventions with care as usual for patients with mental illness. GPs were instructed 
to ask all patients aged 18 - 65 years who they suspected to have Common Mental 
Disorders including, Depression, Anxiety, Stress and Somatoform Disorder to participate, 
and 278 were referred to the study. Patients were assessed using the structured clinical 
interview for DSM-IV Axis I and Axis II (SCID I and SCID II), with the latter refers to 
Personality Disorders [73]. Exclusion criteria were Bipolar or Psychotic Disorder or severe 
Personality Disorder. They were judged to be at risk of committing suicidal acts if they had 
undergone MMI earlier. In Paper II, patients were excluded from the analysis if they were 
recipients of a permanent or temporary Disability Pension at any time during the study 
period, before or after the randomization, or if they were not employed. 
 
Interventions 
The group interventions were provided in groups of six participants. During the period of 
group therapy, the GPs cared for the participants in the same way that they cared for 
patients in the control group. None of the interventions had a specific focus on work 
ability. 
 
Cognitive-Behavioural-Based Therapy 
 
Group CBT was based on generally acknowledged cognitive and behavioural treatment 
principles from the domain of Anxiety and Mood Disorders. In this protocol, the group 
CBT treatment comprised one 120-minute group session per week for 12 weeks led by one 
of two licensed clinical psychologists with training and experience in delivering CBT. The 
first four sessions were focused on, respectively, developing conceptualizations of patients’ 
problems and psycho-education and exposure interventions for Anxiety Disorders and 
behavioral activation for Depression. Sessions 5 to 11 were focused on exposure to feared 
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stimuli and emotional awareness training. The final session was focused on acquiring new 
skills to handle risk situations for relapse.  
 
Multimodal Intervention                                         
 
This was a group intervention following a protocol created by one of the authors (Ruslan 
Savitskij) consisting of a mix of existing group interventions and exercises utilized in a 
variety of therapeutic schools. Prior to the start of group treatment, participants met an 
assistant nurse for an individual appointment where a brief description of the treatment was 
given. During this session, the nurse also collected detailed information about the 
participants’ psychiatric problems and participants were asked to write down their goals 
and ideas for solutions to their problems. The group intervention comprised 150-minute 
group sessions twice a week for 6 weeks and sessions were led by one of three assistant 
nurses with only brief training. The main components of the treatment in the first week 
were a unified goal setting among the group members, psycho-education concerning 
thoughts, emotions, and behaviors that are common in persons with Depressive and 
Anxiety Symptoms. During the second week of treatment, the participants were introduced 
to an exercise where one participant shares a personal problem with the group and obtains 
feedback. A focus was also on the importance of physical training and the participants 
were taught to do a few yoga exercises. The focus of the third and fourth weeks of the 
intervention was on understanding the difference between emotions and thoughts and 
strategies concerning how to deal with conflicts were presented. During the fifth week, 
participants were asked to invite important people in their lives to attend two sessions to 
work on team building. The participants and their guests were encouraged to take part in 
small group activities. During the final two sessions in the sixth week, strategies for 
handling difficult thoughts and emotions in highly stressful situations were presented. 
Following group therapy, each participant also had two additional individual sessions with 
the assistant nurse to discuss individual goals set prior to group therapy. Three assistant 
nurses administered the MMI intervention. They had no formal psychotherapeutic 
education and their training prior to this study was participation in an MMI group 
treatment as a member, and subsequently, as an observer, except for one of the assistant 
nurses who had administered the intervention for a couple of years at the Primary Health 
Care Center prior to the study. They were thoroughly recruited and selected on the basis of 
their personal interest and judged suitability for the task. All three assistant nurses received 
weekly supervision by the originator of MMI or a group therapist. 
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Care as Usual 
Participants in the control group were given Care As Usual, CAU, by GPs at the Primary 
Health Care Centre consisting of appointments with GPs who prescribed medication and 
sick-listing when necessary, with referrals to the counselor at the Primary Health Care 
Center and, more rarely, to a Psychiatric Clinic.  
 
Outcomes 
Since the participants had different psychiatric symptoms and diagnoses, the Mental 
Component Summary (MCS) Score of Short Form 36 (SF-36) [66-69] was used as the 
primary outcome in Paper I and, in Papers III and IV, the Physical Component Summary 
(PCS) with subcomponents was used in addition to the MCS and, in Paper II, the primary 
outcome was sick-listing. Secondary outcomes (Paper I) were measures of Anxiety 
Depressive Symptoms, Obsessive-Compulsive Symptoms and Stress Symptoms. 
Assessment points were at baseline, post-treatment, and at the 1-year follow-up. 
Sick-listing data were obtained from the Social Insurance Agency (SIA). For each month, 
from 24 months before randomization to 24 months afterwards, the number of sick leave 
days was calculated as the sum during the preceding 30 days. 
 
Sample Size 
Assuming a treatment effect of 7% points on the MCS and a SD of 15% points, a minimum 
of 74 persons per group would be needed to achieve an 80% statistical power at the 5% 
significance level (double sided). With an expected dropout rate of 10%, ~80 patients were 
randomly allocated to each treatment arm. 
 
Blinding 
No blinding was used. 
 
Trial procedures 
A baseline assessment (DSM-IV Axis I and II Disorders), along with the Alcohol Use 
Disorders Identification Test (AUDIT) [74] to detect risky alcohol habits was performed 
by two of the investigators [72]. Self-Rating Scales, PSS and CPRS-S-A were used and 
information on such background factors as education, family situation, social support, and 
employment were collected. To measure Personality, the Health-Related Personality 
Inventory (HP5i) [75, 76] was used. Physical activity was assessed (kcal/kg/24h) by letting 
the patients indicate on a nine-step scale their daily activity levels [77, 78]. Written 
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informed consents were collected from all participants. A total of 82% (n = 200) provided 
data at the post treatment assessment and 96% (n = 235) completed the assessment at the 1-
year follow-up. For 24 participants, the 1-year follow-up assessment was delayed 4–19 
months. 
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9 RESULTS 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Assessed for sick-listing in Paper   II 
 
 
 
 
Figure 3. Participant recruitment flow chart.  
 
                                Assessed for eligibility (n=278) 
Excluded before randomization       (n=33) 
Not meeting inclusion criteria         (n= 9) 
Declined to participate                    (n= 7) 
No contact when invited                 (n=17) 
 
                                                                       Randomized (n=245) 
Allocated to MMI (n=80) 
Received allocated intervention 
(n=67) 
Did not receive allocated 
intervention (13) 
n=7, did not start, no contact 
n=6, dropped out, reason: 
-Demanding treatment   (1) 
-Unknown                        (2) 
-Moved                            (2) 
-Schedule problem          (1) 
Allocated to Care As Usual 
(n=81) 
 
 
 
 
 
 
 
 
Allocated to CBT    (n=84) 
Received allocated intervention(n=74) 
Did not receive allocated intervention 
(10) 
n=4, did not start     no contact 
n=6, dropped out, reason: 
-Demanding treatment          (1) 
-Unknown                              (4) 
-Scheduling problems          (1) 
 
                              
Post-assessment, 2 weeks: 
Lost to follow-up (n=1)  
Assessed             (n=66) 
One  year follow-up: 
n=62         Completers 
n=2           Noncompleters         
Late “1 year” follow- up: 
4 - 19 months late 
n=4           Completers 
n=8           Noncompleters 
 
n=66/67 completers available 
data 
 
Analyzed n=76  of 80 
4 did not come to assessment 
Post-assessment 2 weeks: 
Lost to follow-up (n=16) 
Assessed             (n=65) 
One year follow up: 
n=70  
 
Late “1-year” follow up: 
4-19months late 
n=8 
 
Analyzed, n=78 of 81 
3 did not come to assessment 
 
Post-assessment  2 weeks: 
Lost to follow-up (n=5) 
Assessed             (n=69) 
 
One year follow up: 
n=70   Completers 
n=  7   Noncompleters      
Late “1- year” follow up: 
4-19 months late 
n=2    Completers 
n=2     Noncompleters 
n=72/74 completers available data 
 
 
Analyzed, n=81 of 84  
3 did not come to assessment 
Excluded (disability pension, 
unemployed or self-employed) 
n=35 
 
Assessed             (n=45) 
Excluded (disability pension, 
unemployed or self-
employed) n=20 
 
Assessed             (n=61) 
Excluded (disability pension, 
unemployed or self-employed) 
n=26 
 
Assessed             (n=58) 
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9.1 PAPER I-II 
A participant recruitment flow chart is shown in Figure 3. Background data showed that 
most participants were middle-aged women with an average to high educational level. 
Mood Disorders were the predominant diagnoses among the participants (n = 139; 57%) 
and in this group major Depression was the most common diagnosis (73.4%). Anxiety 
Disorders were diagnosed in 91 participants (37.3%) with Unspecified Anxiety being most 
prevalent (37.4%), followed by Specific Phobia (30.8%). For about one-fourth of the 
participants, no diagnosis according to DSM-IV criteria was present at the time of 
the interview. The primary outcome measure was the MCS of SF-36. The mean 
improvement at post-treatment and the 1-year follow-up was significantly higher among 
participants in the MMI group than among those in the CBT and CAU group, table 5. CBT 
participants were significantly more improved than CAU participants. On all three 
subscales of the CPRS-S-A and PSS, MMI showed a significantly higher treatment effect 
than did both CBT and CAU, whereas CBT did not differ from CAU on any of these 
measures. The effect size (Cohen’s d) between MMI and CAU groups was moderate on 
SF-36 MCS, Depression and Stress (PSS).The effect sizes between MMI and CAU were 
small on Anxiety, OCD (Table 6).  
 
Table 4. Background characteristics 
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Table 5. Summary of results at pre-, post- and follow-up assessment 
 
 
Table 6. Estimates of treatment effects based on mixes model analyses and Cohen’s d 
 
 
For all three groups, the majority of patients had 0 sick leave days the month before 
randomization, whereas 20 days was the second most common sick leave pattern. For all 
three groups, sick leave days increased up to the date of randomization, and decreased, in a 
uniform manner, up to two years after the beginning of the trial. There was no clear pattern 
regarding the relationship between groups at different points in time. We did not find lower 
odds for sick listing with active treatment compared with usual care (Table 7) and CBT 
compared with usual care had a significantly elevated OR for sick listing at 24 months. 
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Table 7. Odds ratios (95% CI) for being sick listed as comparison between groups at different times, relative 
to randomization. 1 
 
 
 
Figure 4. Mean number of sick leave days at different points in time, relative to randomization for the three groups. 
CAU refers to “care as usual”. 
9.2 PAPERS III-VI 
Compared to the Swedish reference group, problems with managing current expenditure 
during the last year were more common in the study group. Fewer had someone to share 
their innermost feelings with, compared to the Swedish reference group.  More patients were 
overweight and smoking was more common. In Table 4 diagnoses are described. In the 
study-group, 21.2% had one PD and 8.7% had two or more. The most frequent ones were 
OC PD (13.7%) and avoidant PD (12%). The third most common Disorder was Depressive 
(8.3%), while the others were below 5%; Passive-Aggressive 4.2%, Borderline 2.9%,   
Narcissistic 1.3%, Dependent 0.8% and Antisocial 0.4%. 
Compared to the population data on the Personality Scales, with 50 as the mean for all 
scales, the study group was characterized by Lower Hedonic Capacity (Extraversion) (M = 
44.1, SD 11.2, p <0.001) and Higher Degrees of Negative Affectivity (Neuroticism) (M = 
54.3, SD = 9.8, p <0.001). The group was characterized by a lower degree of Antagonism 
(opposite of Agreeableness) (M = 46 SD= 9.6, p <0.001). The mean score for Impulsivity 
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(opposite of Conscientiousness) was 51.4, SD 11.3, p = 0.044), and, for Alexithymia 
(opposite of Openness) it was 48.7 (SD = 9.2, p = 0.034).  
Figure 4 is a spider diagram showing average scores on the SF-36 dimensions compared to 
the Swedish Normative Data. While the group scored almost the same as the population on 
the Physical Functioning Scale, the points on all other scales were markedly reduced – 
almost halved. The group scored almost the same as the population on PCS, M = 46.43, 
while MCS was almost halved, 25.05, compared to the general population. 
In the regression model for MCS before treatment, Mood Disorder and the degree of 
Depressive Symptoms, together with Stress, were most important and had a negative 
impact. Having an Anxiety Disorder and a high degree of Anxiety Symptoms also had a 
negative impact. Among background factors, lack of an Economic Buffer had a negative 
influence. No PD was included. Among Personality Traits, Impulsivity, as a facet of low 
Conscientiousness, had a negative impact in the Regression Model. In the Regression 
Model for PCS as the outcome variable, being on Sick Leave was the strongest factor, and 
with a negative effect, followed by Being Employed/At Work, with a positive effect. High 
Stress Levels had a positive effect, while a high degree of Anxiety Symptoms and high 
BMI were negatively associated with PCS. Physical Activity had a small positive effect.  
At 12 months (Paper IV), a clear change in the pattern of predictors had appeared (Table 
8). For MCS, two important predictors were now included in the model, Being Employed 
(positive) and Being Born Outside of Sweden (negative). Among the Diagnoses and 
Symptoms, having an Anxiety Disorder still had a negative impact, in contrast to Mood 
Disorder and Depressive Symptoms. One PD (OC) with a negative impact was included in 
the regression model.  
For the Summary Score PCS, Being on Sick Leave at the time for the start of the study, 
having a high degree of Anxiety Symptoms and a high BMI remained as negative 
predictors. Being a Daily Smoker predicted a lower PCS one year after treatment. In 
contrast to before treatment, two Personality Traits were now included in the model, 
Hedonic Capacity and Impulsivity, both with positive values. The positive effect of Stress 
remained. 
The effect of Active Treatment, compared to the Control Condition, on QoL after 12 
months, was strong for MMI with a high and positive influence on MCS and on a level 
with the highest in the Regression Models. CBT had a positive impact on MCS, but a small 
negative impact on PCS.  
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Figure 5. SF-36 dimensions for the study sample compared to Swedish norms. BP (Bodily Pain), RP (Role Physical), 
MH (Mental Health), RE (Role Emotional) , SF (Social Functioning), VT (Vitality -Energy/Fatigue-), GH (General 
Health Perceptions),  PF (Physical Functioning). 
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Variables in the final 
regression model 
MCS PCS 
 Before treatment 12 months after 
treatment 
Before treatment 12 months after 
treatment 
Background     
Sick leave   -6.51 (<0.001) -3.44 (0.007) 
Employed  4.26 (0.015) 4.21 (0.012)  
Born outside Sweden  -6.72(0.008)   
Physical activity   2.46 (0.083)  
Smoking    -2.48 (0.067) 
BMI   -2.81 (0.050) -1.71 (0.140) 
Lack of economic buffer -2.44 (0.091)    
DSM-IV AXIS I and 
symptoms 
    
Affective Disorder -8.87 (<0.001)    
Anxiety Disorder -3.20 (0.01)8 -2.86 (0.099)   
Somatoform Disorder (10 
patient of 245) 
   5.63 (0.083) 
Depressive symptoms -7.54 (<0.001)    
Anxiety symptoms -2.68(0.063)  -3.07 (0.043) -2.77 (0.027) 
Stress -5.14 (0.001)  3.13 (0.035) 2.40 (0.046) 
DSM-IV AXIS II     
OC PD  -3.69 (0.118)   
Personality     
Hedonic capacity    3.83 (0.002) 
Impulsivity -2.50 (0.053)   1.78 (0.131) 
Treatment     
MMI  7.13 (<0.001)  1.83 (0.196) 
CBT  4.13 (0.041)  -1.60 (0.237) 
Table 8. Results of the regression analyses for MCS and PCS before treatment and 12 months after 
treatment . Regression coefficients and p-values are shown for the patient characteristics and for 
belonging to one of the treatment groups CBT or, MMI). P-value in parenthesis. 
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10 DISCUSSION 
With a background of increased awareness of mental problems among patients in primary 
care, including serious problems with Sick Leave, primary care has an urgent needs to treat 
mental illness in an effective manner. Therefore, we made an attempt in 2002 to improve 
the care for patients with Common Mental Disorders. We offered Group Intervention, in 
addition to visits to GPs. Assistant nurses, without therapy training, led manualized group 
interventions for patients with Common Mental Disorders.  After a few years it was 
necessary to evaluate this local manual. CBT was, at this time, the therapy for which there 
were evidence-based manuals available. However, there is a substantial comorbidity 
between Anxiety Disorders and Mood Disorders. David Barlow [25] and his research 
group had at this time developed a Transdiagnostic CBT Protocol (Individual Treatment) 
for patients suffering from both disorders. We aimed to investigate both the Local Manual 
(MMI) and a Group Manual based on David Barlows Unified Protocol for Common 
Mental Disorders and evaluate the effects of these treatments on QoL, symptoms and 
effects on Sick Leave. We also wanted to increase our knowledge concerning patient 
characteristics such as Personality, PD and their impact on the QoL both at inclusion, but 
also one year after treatment.  
10.1 METHODOLOGICAL CONSIDERATIONS 
10.1.1 Paper I 
We chose to perform a Randomized Controlled Study because it is considered to be the 
best method to minimize the risk of bias and compare Care as Usual with Research 
Interventions in a scientifically robust way at a Primary Care Center. Two considerations 
were discussed early on in the research group. Blinding of the Interventions to the 
participant is desirable, which, however, is in this study was not possible since the 
Interventions delivered were distinctly different and this was apparent not only to the 
therapist, but also to the patients.  
There were only two therapists for the CBT-based intervention and three assistant nurses 
leading the MMI. This number of therapists is very low and constituted a risk for the 
project. It also raises questions regarding the generalizability of the results.  
Effectiveness Trials measure the effect under “real world” clinical settings. We wanted to 
be as close as possible to the natural conditions of a primary care setting. Therefore, we 
asked the GPs to refer all eligible patients from their ordinary clinical work i.e. patients 
with Anxiety, Stress, and/or Depressive Symptoms. 
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We used QoL as a primary outcome since we mixed patients with different diagnoses 
although this also increased the challenge since QoL as the outcome suffers from a lack of 
sensitivity and is subject to patients’ Coping Abilities, which also tend to obscure 
measurements of the result. 
The locally Developed Manual for Group Intervention, MMI, had been created by one of 
the authors, Ruslan Savitskij, psychiatrist, and the intervention had been used for several 
years with promising results in a Psychiatric Clinic.  
The CBT-based unified protocol was created for individual treatments. Before the trial 
could start we had to adjust the Protocol to a Group Format. This work was done by two 
young psychologists under the supervision of senior researchers. There was not enough 
time for them to practice their skills with the manual for more than one Group Treatment 
each for the two psychologists. This could be a reason to explain the results of the CBT 
Based Group Therapy. 
10.1.2 Paper II 
The strengths of the study are the Randomized Design and the availability of registry data 
on Sick Leave for all participants. An important limitation is that the study was not 
designed primarily for addressing the sick-listing issue, and therefore we can not evaluate 
its statistical power in this respect; being sick-listed was not an inclusion criterion, which 
probably reduced the study’s ability to demonstrate effects of Psychosocial Interventions 
on Sick Leave. It could have also been useful to include measures other than days on Sick 
Leave, e.g. Self-Reported Work Ability, as in the Work Ability Index [79]. Other 
limitations are the small number of therapists (two and three respectively), which restricts 
the generalizability to other settings, and differences between CBT and MMI in terms of, 
for example, Total Therapy Time. 
10.1.3 Papers III and IV 
One of the limitations of our study is that the group was assessed at a time in their lives 
when they tended to be in an acute phase of worsened psychological well-being. It would 
be interesting to study such primary care patients, who often have recurrent or chronic 
problems, at other points in time to see if the pattern of associated factors would change. 
Another limitation is that the referral to the study was dependent to a high degree on the 
individual physician’s judgement. Finally, there is an overlap between the Assessment of 
Depressive Symptoms in CPRS-S-A and items in the MH Subscale of SF-36, targeting 
Depressive Symptoms. On the other hand, there were, in general, low scores also in 
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domains not directly reflecting symptoms, such as Social Functioning and Role Emotional.  
Furthermore, we did an Additional Analysis with these two subscales as dependent 
variables and found the same two most important predictors for both, i.e., Mood Disorder 
and Stress, as when MCS was used. An instrument focusing on Life Satisfaction rather 
than  Psychological Symptoms, such as the Quality of Life Inventory (QOLI) [80], would 
have been an interesting complement. A strength of the study is its clinical validity since it 
was performed in an ordinary primary care practice. Another strength is that the group was 
extensively examined for Background Factors, Lifestyle, Symptoms, Personality, and 
Psychiatric Diagnoses. 
In Paper IV, we compared predictors for QoL both at inclusion and one year after 
treatment, and we could also compare the effect of treatment with other predictors. One of 
the limitations of the study is that we only used a Self-Report Measure for QoL and for 
many of the predictors such as Lifestyle, Symptoms and Personality. In an unblinded study, 
there can certainly be a bias regarding post treatment QoL-data due to patient reporting being 
influenced by a knowledge of Allocation to Active Treatment or not, sometimes referred to 
as the Hawthorne Effect [81]. Multiple Analyses of correlations made between a number of 
variables and three treatment arms were performed. Thus, it is possible that some of the 
statistically significant correlations might still be due to random events. We conducted 
Complementary Analyses without Symptom Scales and without treatment and found that 
the same predictors applied to the Regression Models.  
10.2 GENERAL DISCUSSION AND MAIN FINDINGS 
10.2.1  Group treatments 
Are group treatments led by assistant nurses in primary care effective treatments for 
CMDs in primary care? 
One important aspect of the studies in this thesis was to elucidate whether or not staff 
without extensive psychiatric training could deliver interventions that led to substantial 
improvements.  Based on data in our trial, I conclude that it appears to be effective to use 
the MMI group intervention (Paper I) in addition to CAU in primary care for patients with 
CMDs regarding their psychological well-being.  
 
Irrespective of the outcome (Mental Components of QoL, Symptoms of Stress, Depression 
or Anxiety), there is a dramatic improvement over time in all three Treatment Groups, 
including CAU. This might be partly due to the fact that patients in the CAU group also 
received some Limited Treatment and Attention, but it probably merely reflects the natural 
course of mild/moderate Depression and Anxiety with Regular Fluctuations. Since patients 
 44 
are more prone to seek health care when the symptoms are worse, there is certainly a 
regression towards the Mean-Like Effect [82] that can be considerable, as indicated by the 
large “response” in the CAU group. This is also demonstrated in Figure 4 where the 
frequency of Sick Leave is shown, before, at and, after inclusion in the trial for the three 
treatment groups. This illustrates the utmost importance of including a Control Group 
(waiting list, CAU or Placebo) in trials of conditions with this type of natural course. 
Without a control group, a comparison of the state of health before and after therapy can be 
grossly misleading. Also, conclusions regarding non-inferiority between active treatment 
arms can be difficult to draw unless there is a control group showing that there is indeed an 
effect, as well as the magnitude of the active interventions.  
Mixing diagnoses in the same trial introduces a risk of dilution of a clinically relevant 
effect for a specific diagnosis. However, when a positive effect is indeed demonstrated, the 
results represent an advantage for small primary care centers. This is particularly important 
since the patient mix encountered in primary care is that of patients with less severe, but 
often multiple, CMDs. Today CBT offers many different evidence-based manuals for 
various Anxiety Disorders as well as specific manuals for Depression. At a smaller primary 
care center it is harder for a single therapist to keep many diagnosis-specific manuals up to 
date and furthermore, for group treatment, the waiting time for filling a group with patients 
with a single diagnosis can be extensive. Many patients in our sample (50%) had both 
Anxiety and Depressive Disorders, which has been demonstrated in many previous studies 
(ref), and increases the need for Transdiagnostic Treatments. 
The difference in the mean score for the primary QoL outcome (MCS SF-36) between 
MMI and CAU was 7.1 post-treatment. The difference between the treatment groups in 
symptom reduction on the CPRS-S-A Depression Scale, which is similar to the 
Montgomery-Åsberg Depression Rating Scale (MADRS), was 4.3 post-treatment. This can 
represent a clinically relevant effect which is well in line with typical results from the 
treatment of Depression with SSRI where post-treatment differences compared to placebo 
on the MADRS Scale is typically between 1 and 3 [83]. Effect sizes (Cohen’s d) for SSRI-
treatment of moderate Depression are typically around 0,3-0,4 [83]. The effect size 
(Cohen’s d) between groups (MMI versus CAU) was 0.55 for the secondary outcome 
measure MADRS. This is to compare with CBT treatment for Depression in relation to 
CAU which has an effect size of g=0.60 according to a recently published meta-analysis 
[84].  
There is a lack of therapists with sufficient training to treat these patients in primary care. 
Using staff with shorter training as a complement to highly trained therapists would 
optimize resources, thereby enabling the latter to focus on the more severe cases, while 
those with less training could take on the milder cases. However, MMI group therapy has 
been shown to be effective in a single centre when supervised by the inventor of the 
module. There is a need to show, in a controlled setting, that these results can be confirmed 
when the same module is used elsewhere without the same supervision. A similar model is 
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implemented in British Psychiatric Outpatient Clinics under the Improving Access to 
Psychological Therapies [85] Program comprising therapists with only little training giving 
treatments as a first step. In our study, MMI as a group intervention led by non-expert 
therapists showed promising results as a treatment for mild to moderate Mental Disorders 
in primary health care. The CBT group treatment based on the Unified Protocol was less 
effective. One possible explanation is that our manual was based on a unified treatment 
manual for individuals and adapted to group therapy with very little training and 
assessment before the trial started. 
10.2.2 Sick Leave 
Do effective treatments reduce Sick Leave? 
In our study, odds for sick listing after active treatment were not significantly lower 
compared to the usual care condition (Table 7). Also, CBT had a significantly elevated 
odds ratio (OR) for sick-listing at the 24-month follow-up compared with care as usual (the 
result should be interpreted with caution due to it being based on one measurement point, a 
low significance level, and multiple comparisons).  
One central finding of this thesis was that although patients reported an improvement in 
terms of psychiatric symptoms and QoL, they did not reduce their risk of being on Sick 
Leave (Figure 5). These results are in line with current research [10, 60]. Reductions of 
Sick Leave do not automatically follow reductions in symptoms. So far, Return-To-Work 
Manuals have not improved Return-To-Work Rates [10, 57], although a few trials have 
found positive effects. There may of course be different effects on different outcomes, but 
there is also a possibility that such subjectively reported outcomes as Disease Symptoms or 
QoL measures are overestimated in a study where patient allocation to the tested therapies 
cannot be concealed. In contrast, Sick Leave as an outcome measure is more robust and 
less likely to be biased by patient expectations and Hawthorne-Like Effects [81]. 
An important aim for future research is also to gain more knowledge about the mechanisms 
of Sick Leave and to investigate whether interventions designed to promote return to work 
for patients with CMDs could lead to a faster reduction of Sick Leave. In conformity with 
Paper II of this thesis, the previous literature on this topic is not very encouraging. Several 
studies have shown none or small effects of return-to-work interventions [86, 87] and it has 
been debated whether other factors rather than the CMD might play a larger role in the risk 
of sick listing for Mental Disorders [57, 58, 88]. Such factors could include Sick Leave 
recommendations from the National Board of Health and Welfare, but also how the 
primary health care system is organized, i.e., where GPs are under pressure to prescribe 
Sick Leave to promote short-term patient satisfaction while the costs of Sick Leave are 
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carried by the Swedish Insurance Agency. Also, as stated by Henderson [88], social, 
medical, psychological, and cultural factors might affect Sick Leave. Considering the 
massive societal burden of Sick Leave costs, more research on factors that influence Sick 
Leave in primary care patients with CMDs is urgently needed.  
10.2.3 Factors associated with and predicting QoL  
Patient characteristics were measured at inclusion (diagnosis, lifestyle, background factors). 
The association of these data to MCS and PCS was described in paper III. In Paper IV the 
same data together with the variable treatment as a comparison, were used to predict MCS 
and PCS one year after treatment. The most important finding were that psychological 
symptoms, mainly depressive symptoms, were most important for determining well-being at 
inclusion. On the other hand, being employed and being Swedish-born were the most 
important long-term predictor. In addition, Anxiety Disorder and Anxiety Symptoms were 
represented most frequently in the four final models, before and after treatment for both 
MCS and PCS. Based on previous research one might expect Neuroticism to be an important 
variable. Neuroticism, a Personality Trait associated to Anxiety and QoL, was not included 
in the final model, and this could possibly be because of the association with Anxiety 
Disorders or Symptoms which by nature could be stronger competitors. The strong positive 
impact of the MMI on MCS was already shown in Paper I, and it was the strongest positive 
predictor.  
Time to pay attention to Personality Disorders and Traits in Primary Care? 
Compared to the general population, the patient sample in our study scored about half on 
all of the SF-36 Scales. Personality Disorders (PDs) were common (29.9 %), with 
obsessive-compulsive PD being the most frequent (13.7%) and avoidant PD being the 
second most frequent PD (12%). Sample scores for the Personality Traits Extraversion 
(Hedonic capacity), Conscientiousness, and Agreeableness were lower whereas scores for 
Neuroticism and Openness were higher, compared to the general population. OC PD was a 
negative predictor for the MCS, together with Anxiety Disorder one year after treatment.  
New research shows the importance of Personality Traits, associated illness and the cost 
for society [89, 90]. The trait Neuroticism has been well-studied and found to be very 
costly due to its associations with both Somatic and Mental Disorders [32, 90]. The 
Netherlands Mental Health Survey and Incidence Study (NEMESIS) compared a group 
with high levels of Neuroticism with a normal reference group. The study found that a high 
degree of Neuroticism was associated with a higher frequency of Mental Disorders and 
  47 
Somatic Diseases such as Asthma, Cardiovascular Disease and Irritable Bowel Syndrome 
(IBS), and therefore greater costs. Also, Neurotic Patients were found to express medically 
unfounded somatic complaints more often. Since Neurotic Patients use more health 
services, costs for visits to General Practitioners and Physiotherapy, as well as additional 
costs for Social Services, were included [32, 90].  
Considering the associations with CMDS and somatic diseases and that Neuroticism often 
precedes the development of these Disorders one potential area for future research is to 
investigate whether or not early interventions for primary care patients with high levels of 
Neuroticism could prevent the development of CMDs and decrease the use of somatic 
health care and the costs. 
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11 CONCLUSIONS 
 
 Transdiagnostic group treatment led by assistant nurses in a primary care setting 
can be effective for patients with CMD.  
 A decrease in psychological symptoms and increased well-being did not seem to 
have an effect on Sick Leave.  
 For primary care patients with mild to moderate Mental Illness, Mood Disorder and 
Depressive Symptoms were the strongest factors associated with negative influence 
on the MCS. 
 Effective treatment and being employed had the strongest positive impact on MCS 
one year after treatment. PD had the strongest negative impact together with Being 
Born Outside Sweden one year after treatment.  
 Increased priority for the treatment of CMD in primary care is of great importance. 
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12 IMPLICATIONS AND FUTURE PERSPECTIVES 
 
There are several clinical implications of the studies described in this thesis. First and 
foremost, this thesis adds to the previous body of literature demonstrating that one of the 
largest patient groups in primary care, i.e., those with CMDs, can achieve large 
improvements in the QoL if offered a brief and structured psychological treatment. It is 
there for essential, and in line with recommendations from example NICE and the NBHW, 
that primary care is organized in a way that makes implementation of psychological 
treatment possible. This requires staff with adequate competence in detecting CMDs and 
conducting psychiatric assessments, as well as accessibility to trained therapists. One 
major challenge for primary care to achieve this aim is to ensure that continuous medical 
education is provided and that mental health care professionals, e.g., psychologists, are 
hired to a larger extent than today. One important aspect of the studies in this thesis was 
that staff without extensive psychiatric training could deliver therapies that led to large 
improvements. This might mean that an increased accessibility to effective psychological 
treatment could be achieved, in spite of a shortage of highly skilled CBT psychologists, if 
nurses are given a brief training and regular supervision. It is, however, important that 
psychologists with an overarching responsibility for the assessment procedures and 
treatment processes are also well represented in the primary care work force. 
 If psychological treatment would be implemented on a large scale in primary care there 
would probably be substantial positive effects in terms of general health in the population, 
but it would also put less strain on GPs and perhaps also reduce the overutilization of 
somatic health care resources observed in patients with CMDs [32, 90]. Implementation of 
evidence-based psychological treatment would thus likely be of high value for the patient, 
the health care system, and society as a whole.  
One central finding of this thesis was that although patients reported an improvement in 
terms of psychiatric symptoms, they did not decrease their sick leave time. That is, despite 
reporting that they were feeling better, they remained on Sick Leave.  
Thus, we found interesting results from the local variant of the group therapy while the 
group therapy based on CBT was less conclusive. Partly as a consequence of these results, 
we have started new trials at Gustavsberg.  
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13 SUMMARY IN SWEDISH 
 
Bakgrund: Depression, ångest och stressrelaterad psykisk ohälsa är vanliga psykiska 
åkommor bland primärvårdspatienter. Många får vare sig diagnos eller behandling. 
Vanliga psykiska åkommor är förknippade med stora samhällskostnader och är 
huvudsakliga orsaker till sjukfrånvaro bland primärvårdspatienter. Tillgången på effektiva 
behandlingsmetoder inom primärvården är begränsad. Sambanden mellan 
behandlingsrelaterade faktorer, kliniska variabler, patientvariabler samt sjukfrånvaro och 
livskvalitet är inte väl undersökta. Ytterligare forskning är nödvändig för att såväl 
identifiera faktorer associerade med hälsorelaterade utfallsmått som utveckla 
behandlingsmetoder som är väl anpassade för primärvården.  
Syfte: Målet med avhandlingen var att undersöka följande: a) Effekterna av två olika 
gruppbehandlingar inom primärvården för vanliga psykiska åkommor (Studie I), b) 
effekterna av effektiva behandlingar inom primärvården på sjukfrånvaro (Studie II), c) 
sambanden mellan patientegenskaper och livskvalitet (Studie III) och d) Hur 
patientvariabler respektive psykologisk behandling kan förutsäga livskvalitet vid 
ettårsuppföljning (Studie IV).   
Metod: En stor randomiserad kontrollerad studie genomfördes. I Studie I jämfördes 
effekterna av en transdiagnostisk gruppbehandling baserad på kognitiv beteendeterapi 
(KBT) (n= 80) och en grupp som fick behandling med Multimodal Intervention(MMI) ledd 
av undersköterskor (n= 84) med effekterna av sedvanlig behandling (n=81). Studie II 
jämförde effekterna av gruppbehandling med CBT (n=45) samt MMI (n=58) med 
effekterna av sedvanlig behandling (n=61) på sjukfrånvaro. Studie III undersökte 
sambanden mellan patientvariabler och livskvalitet genom en linjär regressionsmodell. I 
Studie IV gjordes samma analys som i Studie III avseende livskvalitet vid 
ettårsuppföljning och en jämförelse gjordes med effekten av behandling genom en linjär 
regressionsmodell. Livskvalitet mättes med summan av Mental Component Summary 
(MCS), Physical Component Summary (PCS) i korta versionen av 36 (SF-36). 
Resultat: Studie 1: MMI-gruppen förbättrades signifikant mer än både KBT-gruppen och 
gruppen som fått sedvanlig behandling. KBT-gruppen förbättrades signifikant mer än 
gruppen som fått sedvanlig behandling. Studie 2: Medelantalet sjukdagar sjönk direkt efter 
randomiseringen och ingen av gruppbehandlingarna med MMI och KBT gav lägre odds för 
sjukskrivning jämfört med sedvanlig behandling. Studie 3: depressiva sjukdomar och 
symtom hade störst effekter på livskvalitet (MCS). Studie 4: bakgrundsfaktorer som att ha 
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en anställning, vara utrikesfödd (omvänd) och att ha en personlighetsstörning (omvänd) var 
starka prediktorer av livskvalitet vid ettårsuppföljning. Den starkaste prediktorn av MCS 
vid ettårsuppföljningen var gruppbehandlingen med MMI. 
Slutsatser: Transdiagnostisk gruppbehandling ledd av undersköterskor kan vara effektiv 
för patienter med vanliga psykiska åkommor inom primärvården. En minskning av 
psykiska symtom och ett ökat välbefinnande verkar inte ha någon effekt på sjukfrånvaro. 
Depressiva syndrom och symtom var faktorerna med störst negativ påverkan på MCS hos 
primärvårdspatienter med mild till måttlig psykisk ohälsa före behandling. Ett år efter 
behandling så var personlighetssyndrom samt ångestsjukdom de starkaste negativa 
faktorerna. Faktorer med positiv påverkan var att ha ett arbete samt att vara född i Sverige. 
Starkast positiv effekt på livskvalitet var MMI behandling ett år efter behandling. 
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14 LEARNING AND OUTCOMES 
 
I have gained new knowledge on a range of scientific issues. I have also learned how 
important psychological treatment is in order to support and to give care to all patients at the 
primary care center.  
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